France halts Valneva’s chikungunya vaccine use in seniors
French health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after serious…
News
J&J’s Tremfya gains EC marketing authorisation for ulcerative colitis
Innorna secures dual FDA designations for Wilson’s disease mRNA therapy
Merck KGaA strikes $3.9bn deal for SpringWorks
Amgen to invest $900m in Ohio manufacturing facility
China approves InnoCare Pharma’s BTK inhibitor for lymphoma
Merck KGaA nears $3.5bn deal for SpringWorks
FDA free to pursue semaglutide compounders after latest court ruling
